A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Healthy

Interventions

DRUG

Citalopram HBr 40 mg tablets, single dose

A: Experimental Subjects received Purepac formulated products under fasting conditions

DRUG

CelexaTM 40 mg tablets, single dose

B: Active comparator Subjects received Forest Labs formulated products under fasting conditions

Trial Locations (1)

Algorithme Pharma Inc., Montreal